Hall Ashley
- SEC CIK
- 0001801842
No open-market purchases or sales filed in the past year.
Current role at each company
- GPCR Structure Therapeutics Inc.Chief Development Officeras of Mar 23, 2026
- OKUR OnKure Therapeutics, Inc.Chief Development Officeras of Aug 29, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hall Ashley as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
OKUR OnKure Therapeutics, Inc.
Chief Development Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 29, 2023 (view filing) | Aug 28 | 1 day | Hall AshleyChief Development Officer | SSale | −15.6K | $6.28 | −$98.1K | −28.3%39.6K after |